Lexaria Bioscience Corp (LXX.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
| 10-2009 | 10-2008 | 10-2007 | 10-2006 | 10-2005 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 342 | 453 | 148 | 82 | N/A |
| Income taxes - deferred | N/A | -33 | N/A | N/A | N/A |
| Accounts receivable | -27 | 23 | -25 | -13 | N/A |
| Accounts payable and accrued liabilities | 235 | N/A | N/A | N/A | N/A |
| Other Working Capital | 214 | 1 | -20 | 8 | 33 |
| Other Operating Activity | -801 | -415 | -323 | -230 | -76 |
| Operating Cash Flow | $-36 | $29 | $-219 | $-153 | $-42 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | -376 | -2,089 | -1,530 | -259 |
| Other Investing Activity | -224 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-224 | $-376 | $-2,089 | $-1,530 | $-259 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 182 | N/A | N/A | N/A | N/A |
| Debt Repayment | -266 | N/A | N/A | N/A | N/A |
| Common Stock Issued | N/A | N/A | 1,050 | 105 | 1,165 |
| Other Financing Activity | 5 | 939 | 50 | 2,000 | 0 |
| Financing Cash Flow | $-79 | $939 | $1,100 | $2,105 | $1,165 |
| Beginning Cash Position | 670 | 78 | 1,285 | 864 | 0 |
| End Cash Position | 330 | 670 | 78 | 1,285 | 864 |
| Net Cash Flow | $-339 | $592 | $-1,207 | $422 | $864 |
| Free Cash Flow | |||||
| Operating Cash Flow | -36 | 29 | -219 | -153 | -42 |
| Capital Expenditure | -224 | -582 | -2,089 | -1,530 | -259 |
| Free Cash Flow | -260 | -553 | -2,307 | -1,683 | -302 |